| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/12/2001 | WO2000002521A3 Symptomatic relief of allergic reactions |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007860 Immunology response |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | US20010007661 Or mutein or salt thereof, for treating or preventing Sjogren's syndrome |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | CA2397714A1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396399A1 Methods for protein transfer |
| 07/12/2001 | CA2396222A1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 07/12/2001 | CA2396173A1 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | CA2396068A1 Antisense antibacterial cell division composition and method |
| 07/12/2001 | CA2396036A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 07/12/2001 | CA2395945A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395636A1 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2394730A1 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | CA2394597A1 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114322A1 Tandem immuno-assay for cancer |
| 07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 07/11/2001 | EP1114172A1 Transfer method for specific cellular localisation of nucleic acids |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
| 07/11/2001 | EP1114064A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 07/11/2001 | EP1113819A2 Antibody directed enzyme prodrug therapy (adept) with glucuronidase |
| 07/11/2001 | EP1113818A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 07/11/2001 | EP1113816A2 Novel influenza virus vaccine composition |
| 07/11/2001 | EP1113815A1 Immunogenic compositions and uses thereof |
| 07/11/2001 | EP1113814A1 Human chorionic gonadotropin vaccines |
| 07/11/2001 | EP1113813A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner |
| 07/11/2001 | EP1113812A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase |
| 07/11/2001 | EP1113810A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/11/2001 | EP1113777A2 Novel hepatitis c virus peptides and uses thereof |
| 07/11/2001 | EP0760676B1 Materials and methods for treatment of plaquing diseases |
| 07/11/2001 | CN1303436A Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303394A Peptide compound for preventing and treating HIV infection and immunity diseases |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/11/2001 | CN1303301A Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303288A Combination therapy for treatment of tumors |
| 07/11/2001 | CN1302890A Human protein translation initiation factor and its coding sequence |
| 07/11/2001 | CN1302876A Human charcot-leyden crystal 4, its coding sequence, its preparing process and its application |
| 07/11/2001 | CN1302875A Human Charcot-leyden crystal 5, its coding sequence, its preparing process and its application |
| 07/11/2001 | CN1302870A Human NADH ubiquinone oxido-reductase 20KD subunit and its coding sequence |
| 07/11/2001 | CN1302867A Polypeptide-human transposase 105 and polynucleotide for coding it |
| 07/11/2001 | CN1302816A Polypeptide-human DnaJ protein 42 and polynucleotide for coding it |
| 07/11/2001 | CN1302815A Polypeptide-human COP9 compound subunit 30 and polynucleotide for coding it |
| 07/11/2001 | CN1302662A Oral immune using plant product containing non entero pathogene antigen |
| 07/11/2001 | CN1302652A Oral immune using plant product containing non entero pathogene antigen |
| 07/11/2001 | CN1302651A Oral immune using plant product containing hepatitis surface antigen |
| 07/11/2001 | CA2331012A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/10/2001 | US6258945 HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same |
| 07/10/2001 | US6258937 Hepadnavirus receptor |
| 07/10/2001 | US6258936 SpoIIIE |
| 07/10/2001 | US6258788 Induction of protective immune response to tick borne flavivirus proteins |
| 07/10/2001 | US6258599 Compositions and methods for treating viral infections |
| 07/10/2001 | US6258597 Stimulation of hematopoietic cells in vitro |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258579 I-kappa-b kinase signalsome capable of specifically phosphorylating i-kappa-b-alpha and i-kappa-b-beta; antiinflammatory agents; anticarcinogenic agents; viricides; treatment of autoimmune and nervous system disorders |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258564 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method the hybirdomas and antigen proteins recognized by the antibodies |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258364 Isolated carbohydrate epitope; immunocontraceptive vaccines; semen detection; medical diagnosis; antifertility agents |
| 07/10/2001 | US6258362 Genetically attenuated; vaccine contains polysaccharide and/or amino acid source, buffer, and monosaccharide, oligosaccharide, or sugar alcohol |
| 07/10/2001 | US6258359 Antiulcer agents, gastrointestinal disorders |
| 07/10/2001 | US6258358 Targeted immunostimulation with bispecific reagents |
| 07/10/2001 | US6258353 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 07/10/2001 | US6258341 Drug dispersion for oral inhalation and pulmonary absorption |
| 07/10/2001 | CA2060666C Antigenic epitopes present on membrane-bound but not secreted iga |
| 07/10/2001 | CA2032505C Coat transmembrane glycoprotein antigens of a hiv-2 type human retrovirus and antigens sharing immunological similarities |
| 07/05/2001 | WO2001048485A2 Selecting library members capable of binding to epitopes |
| 07/05/2001 | WO2001048482A1 Interaction between cd14 and hbv components |
| 07/05/2001 | WO2001048208A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | WO2001048205A2 Murine neu sequences and methods of use therefor |
| 07/05/2001 | WO2001048163A2 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | WO2001048162A2 Method for the production of vitamin a |
| 07/05/2001 | WO2001048161A2 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | WO2001048020A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | WO2001048017A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 07/05/2001 | WO2001047962A2 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | WO2001047961A1 P. gingivalis antigenic composition |
| 07/05/2001 | WO2001047959A2 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/05/2001 | WO2001047955A2 Improvements in or relating to immune responses to hiv |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047555A1 Treating cancers associated with overexpression of class i family of receptor tyrosine kinases |
| 07/05/2001 | WO2001047554A1 Stable antibody compositions and injection preparations |
| 07/05/2001 | WO2001047553A1 Micelle-forming lipopeptides targeted at antigen presenting cells useful as vaccine adjuvants |
| 07/05/2001 | WO2001047552A1 Polysialic acid-klh conjugate vaccine |